BIAL appoints Joerg Holenz as R&D General Manager
November 8, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments
BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease
November 8, 2021Sales and Marketing
A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …
HLB’s liver cancer treatment awarded Orphan Drug Status by FDA
November 8, 2021Sales and Marketing
HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …
UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%
November 8, 2021Sales and Marketing
The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …
FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID
November 5, 2021Medical Communications
The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …
Pfizer and Entia’s breast cancer home test in final stages
November 5, 2021Medical Communications
Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …
Republicans governors retaliate against Biden vaccine mandate
November 5, 2021Medical Communications
Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …
Scientists identify new drug combination for children with brain cancer
November 5, 2021Medical Communications
A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …
England COVID-19 prevalence rose to highest levels in October, study finds
November 4, 2021Business Services
Imperial College London have said that COVID-19 rates in England rose to its highest level on record in October. This …
WHO grants emergency use listing to COVID vaccine
November 4, 2021Business Services
WHO has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use in individuals aged 18 years and above. Two doses …
FDA fast track oral treatment of dermatitis
November 4, 2021Business Services
UNION therapeutics have received a Fast Track designation from the FDA for their oral orismilast for the treatment of moderate …
HPV vaccine cutting cervical cancer rates by 87%
November 4, 2021Business Services
The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between …
HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments
HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Study reveals Alzheimer’s spreads differently than previously thought
November 3, 2021Research and Development
A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …
Clinical trial shows promise for aggressive eye cancer treatment
November 3, 2021Research and Development
A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …
Outsourcing in clinical trials: A response to rising challenges
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Risking it all after the pandemic: How companies can pick up the slack post-COVID-19
November 3, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment
November 3, 2021Research and Development
Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …
Covid jabs more effective than virus at preventing infection
November 3, 2021Research and Development
A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …
Beverley Carr appointed Chief Business Officer for Amphista Therapeutics
November 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments
Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Latest content
